Publications by authors named "Joseph Chow"

Claim this Profile
O
On the Optimal Treatment of Metallo-Beta-Lactamase-Producing Enterobacterales Infections Using Aztreonam and Avibactam.
Yehuda Carmeli, José Miguel Cisneros, Mical Paul, Joseph W Chow, George L Daikos

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam-Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales.
Susan R Raber, Rujia Xie, Halley Rogers, Elena Soto, Francis F Arhin, Joseph W Chow

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic/pharmacodynamic modeling to optimize aztreonam-avibactam dose regimens for adult patients.
Rujia Xie, Halley Rogers, Joseph W Chow, Elena Soto, Susan R Raber

Antimicrob Agents Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aztreonam-avibactam for the treatment of serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens: a Phase 3 randomized trial (ASSEMBLE).
George L Daikos, José Miguel Cisneros, Yehuda Carmeli, Minggui Wang, Chee Loon Leong, Joseph W Chow

JAC Antimicrob Resist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.
Yehuda Carmeli, José Miguel Cisneros, Mical Paul, George L Daikos, Minggui Wang, Joseph W Chow

Lancet Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program.
John E Mazuski, Florian Wagenlehner, Antoni Torres, Yehuda Carmeli, Joseph W Chow

Infect Dis Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobility in post-pandemic economic reopening under social distancing guidelines: Congestion, emissions, and contact exposure in public transit.
Ding Wang, Mohammad Tayarani, Brian Yueshuai He, Jingqin Gao, Joseph Y J Chow

Transp Res Part A Policy Pract· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using an International Role-Modeling Pedagogy to Engage First-Year Occupational Therapy Students in Learning Professionalism.
Chi-Wen Chien, Sung Yu Chloe Mo, Joseph Chow

Am J Occup Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Ceftazidime-Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme.
Karen Cheng, Paul Newell, Joseph W Chow, Helen Broadhurst, David Wilson

Drug Saf· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
Gregory G Stone, Patricia A Bradford, Margaret Tawadrous, Dianna Taylor, Mary Jane Cadatal, Joseph W Chow

Antimicrob Agents Chemother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Approaches to Enhance the Processivity and Salt Tolerance of Staphylococcus aureus DNA Polymerase.
Bing Zhai, Joseph Chow, Qi Cheng

Protein J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme.
Gregory G Stone, Paul Newell, Leanne B Gasink, Helen Broadhurst, Angela Wardman, Joseph W Chow

J Antimicrob Chemother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.
Antoni Torres, Nanshan Zhong, Jan Pachl, Jean-François Timsit, Marin Kollef, Joseph W Chow

Lancet Infect Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
Xinyu Qin, Binh Giang Tran, Min Ja Kim, Lie Wang, Dung Anh Nguyen, Joseph W Chow

Int J Antimicrob Agents· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis.
Wendy Comisar, Peng Sun, Susan Li, Carole Sable, Michael Schwartz, Joseph Chow

Clin Pharmacol Drug Dev· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients.
C F Ng, Rachel Yeung, Peter K F Chiu, N Y Lam, Joseph Chow

Hong Kong Med J· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test.
Fiona K Y Wong, Johannes C Y Ching, Joseph K F Chow

Open Virol J· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
Johan A Maertens, Luis Madero, Anne F Reilly, Thomas Lehrnbecher, Andreas H Groll, Joseph W Chow

Pediatr Infect Dis J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
Marta Toth, Hilary Frase, Joseph W Chow, Clyde Smith, Sergei B Vakulenko

Antimicrob Agents Chemother· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety experience with caspofungin in pediatric patients.
Theoklis Zaoutis, Thomas Lehrnbecher, Andreas H Groll, William J Steinbach, Hasan S Jafri, Joseph W Chow

Pediatr Infect Dis J· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).
Fernando Baquero, Po-Ren Hsueh, David L Paterson, Flávia Rossi, Grant V Bochicchio, Joseph W Chow

Surg Infect (Larchmt)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.
Xavier Sáez-Llorens, Mercedes Macias, Padmanabha Maiya, Juan Pineros, Hasan S Jafri, Joseph W Chow

Antimicrob Agents Chemother· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Source of phosphate in the enzymic reaction as a point of distinction among aminoglycoside 2''-phosphotransferases.
Marta Toth, Joseph W Chow, Shahriar Mobashery, Sergei B Vakulenko

J Biol Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Theoklis E Zaoutis, Hasan S Jafri, Li-Min Huang, Franco Locatelli, Asher Barzilai, Joseph W Chow

Pediatrics· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminoglycoside 2''-phosphotransferase type IIIa from Enterococcus.
Adriana Badarau, Qicun Shi, Joseph W Chow, Jaroslav Zajicek, Shahriar Mobashery

J Biol Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis